Fig. 3.
Fig. 3. Time course effects of local treatment with antibodies (A) or peptides (B) on PAF-stimulated (10−7 mol/L) PMN locomotion in the rat mesentery. / (A) Anti-α2 (mAb Ha1/29) (•), combined anti-α2 and anti-β1 (mAb HMβ1-1) (○), anti-α4 (mAb TA-2) (▾), and anti-α5 (mAb HMα5-1) (▿) integrin antibodies (100 μg/mL). (B) The α2β1-binding peptide DGEA (25 mM) (•), α4β1-binding peptide SLIDIP (500 μM) (▾), and α5β1-binding peptide RGDGW (500 μM) (▿). Data are based on calculation of mean migration velocity during 10- to 20-minute periods and presented as means ± SD of 4 to 5 experiments for each reagent tested.

Time course effects of local treatment with antibodies (A) or peptides (B) on PAF-stimulated (10−7 mol/L) PMN locomotion in the rat mesentery.

(A) Anti-α2 (mAb Ha1/29) (•), combined anti-α2 and anti-β1 (mAb HMβ1-1) (○), anti-α4 (mAb TA-2) (▾), and anti-α5 (mAb HMα5-1) (▿) integrin antibodies (100 μg/mL). (B) The α2β1-binding peptide DGEA (25 mM) (•), α4β1-binding peptide SLIDIP (500 μM) (▾), and α5β1-binding peptide RGDGW (500 μM) (▿). Data are based on calculation of mean migration velocity during 10- to 20-minute periods and presented as means ± SD of 4 to 5 experiments for each reagent tested.

Close Modal

or Create an Account

Close Modal
Close Modal